Live attenuated Leishmania major H-line vaccine (Kerman University of Medical Sciences)
减毒活利什曼原虫H系疫苗
Report date: 2022/11/20 15:02:31
Base Information
Drug NameLive attenuated Leishmania major H-line vaccine (Kerman University of Medical Sciences)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKerman University Of Medical SciencesUniversity Of Glasgow
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of GlasgowKerman University Of Medical Sciences
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A